Phentolamine hydrochloride in prevention of cutaneous necrosis due to levarterenol.
D000317:Adrenergic alpha-Antagonists; D035843:Biomedical Research; D006801:Humans; D009638:Norepinephrine / Q000009:adverse effects*; D010646:Phentolamine; D012871:Skin Diseases / Q000628:therapy*
D000317:Adrenergic alpha-Antagonists; D009638:Norepinephrine; D010646:Phentolamine
ARTERENOL/injurious effects; SKIN DISEASES/therapy